{"id":"fb9bec01-cadc-5c2a-bea9-ad1a268cb8e6","stable_key":"e0ea2d6a-7429-5e9f-b774-41e5e3288da3:e-clin-pivens-histology","predicate":"increases","statement":"PIVENS met its histological improvement endpoint in 43% of vitamin E recipients versus 19% of placebo recipients (P=0.001).","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"5158f1e4-5122-5f77-b923-1431069b6597","mechanism_event_label":"The studied vitamin E treatment improved a defined liver-biopsy outcome in adults with NASH without diabetes.","subject":{"id":"ae6048a7-d112-5d3a-8e7c-ad5a152642f9","slug":"rrr-alpha-tocopherol","display_name":"RRR-alpha-tocopherol","entity_type_key":"small_molecule"},"object":{"id":"85ba5bf3-3762-53da-bd03-5022f5ad7de7","slug":"steatohepatitis-histological-improvement","display_name":"Steatohepatitis histological improvement","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"5158f1e4-5122-5f77-b923-1431069b6597","stable_key":"e0ea2d6a-7429-5e9f-b774-41e5e3288da3:e-clin-pivens-histology-event","event_type":"observed_intervention","label":"The studied vitamin E treatment improved a defined liver-biopsy outcome in adults with NASH without diabetes.","description":"PIVENS met its histological improvement endpoint in 43% of vitamin E recipients versus 19% of placebo recipients (P=0.001).","status":"provisional","compartment":null,"participants":[{"entity":{"id":"ae6048a7-d112-5d3a-8e7c-ad5a152642f9","slug":"rrr-alpha-tocopherol","display_name":"RRR-alpha-tocopherol","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"85ba5bf3-3762-53da-bd03-5022f5ad7de7","slug":"steatohepatitis-histological-improvement","display_name":"Steatohepatitis histological improvement","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"cross_nutrient","value_text":"false","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"RRR-alpha-tocopherol 800 IU/day for 96 weeks; E group n=84, placebo n=83.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Histological endpoints in a defined nondiabetic NASH population, not proof of general liver benefit, fibrosis reversal, cirrhosis prevention or long-term survival benefit.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Vitamin E research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"vitamin-e","display_name":"Vitamin E","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The studied vitamin E treatment improved a defined liver-biopsy outcome in adults with NASH without diabetes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Liver biopsy","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"4ccbda5d-2108-59f6-a091-4a4247577809","evidence_kind":"source_excerpt","locator":"Lines 1401-1412","start_line":1401,"end_line":1412,"excerpt":"### e-clin-pivens-histology\nPIVENS met its histological improvement endpoint in 43% of vitamin E recipients versus 19% of placebo recipients (P=0.001).\nCondition category: normal\nnutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The studied vitamin E treatment improved a defined liver-biopsy outcome in adults with NASH without diabetes.\norganism: Homo sapiens\ntissue_or_cell_type: Liver biopsy\nexperimental_model: PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes\nlimitations: Histological endpoints in a defined nondiabetic NASH population, not proof of general liver benefit, fibrosis reversal, cirrhosis prevention or long-term survival benefit.\nexposure: RRR-alpha-tocopherol 800 IU/day for 96 weeks; E group n=84, placebo n=83.\ncross_nutrient: false\n[e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929","model_system":"PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"3ac41dba-4727-5116-a556-ac3bbb0dc41c","stable_key":"import-e0ea2d6a-7429-5e9f-b774-41e5e3288da3","title":"Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"a90b6565e092c6a2da07f74cf758792c2cf63b40746260c8ff12bd64322c36f4","revision_id":"956793d1-23e4-5397-9291-25c1732a8e02","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}